Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation

Amira Al-Uzri, Kurt Freeman, Jordan Wade, K. Clark, L. A. Bleyle, M. Munar, Dennis Koop

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The use of DBSs for home monitoring has been limited due to unsatisfactory blood sampling and analytical difficulties. The aim of this longitudinal feasibility trial was to assess the utility of DBS to monitor TAC and Cr at home in transplant recipients. A total of 30 participants (2-21 years, mean±SD, 13.6±5.4 year) were enrolled over 12 months. Eighteen were males. Monthly DBS samples were obtained at home and mailed to the central laboratory for analysis of TAC and Cr. Nineteen patients completed the study, and 216 cards were received in the laboratory from a total of 279 cards expected, with 416/519 (80%) blood spots being suitable for analysis. We found a high correlation between blood TAC and Cr levels by DBS and the clinical laboratory, R2=.81 and .95, respectively. Fifteen parents and 15 youth completed measures of satisfaction with and preference for DBS testing. All but one parent/caregiver and youth reported satisfaction and preference for this method of testing over laboratory blood draws. We conclude that home DBS monitoring is a feasible method to monitor TAC and Cr in pediatric transplant recipients.

Original languageEnglish (US)
JournalPediatric Transplantation
DOIs
StateAccepted/In press - 2017

Fingerprint

Kidney Transplantation
Longitudinal Studies
Caregivers
Parents
Pediatrics
Transplant Recipients

Keywords

  • Dried blood spots
  • Home monitorirng
  • Pediatric kidney transplantation
  • Tacrolimus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

@article{9bff843474394dcbaa54db45aa2fb411,
title = "Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation",
abstract = "The use of DBSs for home monitoring has been limited due to unsatisfactory blood sampling and analytical difficulties. The aim of this longitudinal feasibility trial was to assess the utility of DBS to monitor TAC and Cr at home in transplant recipients. A total of 30 participants (2-21 years, mean±SD, 13.6±5.4 year) were enrolled over 12 months. Eighteen were males. Monthly DBS samples were obtained at home and mailed to the central laboratory for analysis of TAC and Cr. Nineteen patients completed the study, and 216 cards were received in the laboratory from a total of 279 cards expected, with 416/519 (80{\%}) blood spots being suitable for analysis. We found a high correlation between blood TAC and Cr levels by DBS and the clinical laboratory, R2=.81 and .95, respectively. Fifteen parents and 15 youth completed measures of satisfaction with and preference for DBS testing. All but one parent/caregiver and youth reported satisfaction and preference for this method of testing over laboratory blood draws. We conclude that home DBS monitoring is a feasible method to monitor TAC and Cr in pediatric transplant recipients.",
keywords = "Dried blood spots, Home monitorirng, Pediatric kidney transplantation, Tacrolimus",
author = "Amira Al-Uzri and Kurt Freeman and Jordan Wade and K. Clark and Bleyle, {L. A.} and M. Munar and Dennis Koop",
year = "2017",
doi = "10.1111/petr.12983",
language = "English (US)",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation

AU - Al-Uzri, Amira

AU - Freeman, Kurt

AU - Wade, Jordan

AU - Clark, K.

AU - Bleyle, L. A.

AU - Munar, M.

AU - Koop, Dennis

PY - 2017

Y1 - 2017

N2 - The use of DBSs for home monitoring has been limited due to unsatisfactory blood sampling and analytical difficulties. The aim of this longitudinal feasibility trial was to assess the utility of DBS to monitor TAC and Cr at home in transplant recipients. A total of 30 participants (2-21 years, mean±SD, 13.6±5.4 year) were enrolled over 12 months. Eighteen were males. Monthly DBS samples were obtained at home and mailed to the central laboratory for analysis of TAC and Cr. Nineteen patients completed the study, and 216 cards were received in the laboratory from a total of 279 cards expected, with 416/519 (80%) blood spots being suitable for analysis. We found a high correlation between blood TAC and Cr levels by DBS and the clinical laboratory, R2=.81 and .95, respectively. Fifteen parents and 15 youth completed measures of satisfaction with and preference for DBS testing. All but one parent/caregiver and youth reported satisfaction and preference for this method of testing over laboratory blood draws. We conclude that home DBS monitoring is a feasible method to monitor TAC and Cr in pediatric transplant recipients.

AB - The use of DBSs for home monitoring has been limited due to unsatisfactory blood sampling and analytical difficulties. The aim of this longitudinal feasibility trial was to assess the utility of DBS to monitor TAC and Cr at home in transplant recipients. A total of 30 participants (2-21 years, mean±SD, 13.6±5.4 year) were enrolled over 12 months. Eighteen were males. Monthly DBS samples were obtained at home and mailed to the central laboratory for analysis of TAC and Cr. Nineteen patients completed the study, and 216 cards were received in the laboratory from a total of 279 cards expected, with 416/519 (80%) blood spots being suitable for analysis. We found a high correlation between blood TAC and Cr levels by DBS and the clinical laboratory, R2=.81 and .95, respectively. Fifteen parents and 15 youth completed measures of satisfaction with and preference for DBS testing. All but one parent/caregiver and youth reported satisfaction and preference for this method of testing over laboratory blood draws. We conclude that home DBS monitoring is a feasible method to monitor TAC and Cr in pediatric transplant recipients.

KW - Dried blood spots

KW - Home monitorirng

KW - Pediatric kidney transplantation

KW - Tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=85021213452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021213452&partnerID=8YFLogxK

U2 - 10.1111/petr.12983

DO - 10.1111/petr.12983

M3 - Article

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

ER -